US · Healthcare · Diagnostics & Research
Analysts rate bioAffinity Technologies, Inc. a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $6.00.
| Fund | Stake |
|---|---|
| Vanguard Capital Management, LLC | 0.88% |
| Geode Capital Management, LLC | 0.77% |
| J. Safra Sarasin Holding AG | 0.68% |
| Vanguard Fiduciary Trust Co | 0.49% |
| Schonfeld Strategic Advisors LLC | 0.39% |
| State Street Corp | 0.23% |
| Northern Trust Corp | 0.20% |
| UBS Group AG | 0.15% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for bioAffinity Technologies, Inc. — free to start.
Google PlayApp StoreData updated 2026-09-18.